4//SEC Filing
Rubin Steven D 4
Accession 0001493152-26-002033
CIK 0001412486other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:10 PM ET
Size
6.2 KB
Accession
0001493152-26-002033
Insider Transaction Report
Form 4
Rubin Steven D
Director
Transactions
- Award
Stock Options (Right to Buy)
[F1]2026-01-09+16,410→ 16,410 totalExercise: $1.10Exp: 2036-01-09→ Common Stock (16,410 underlying)
Footnotes (1)
- [F1]The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date.
Signature
/s/ Steven Rubin|2026-01-13
Documents
Issuer
Cocrystal Pharma, Inc.
CIK 0001412486
Entity typeother
Related Parties
1- filerCIK 0001381874
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:10 PM ET
- Size
- 6.2 KB